Retatrutide cannot be prescribed on the NHS and must not be obtained outside a regulated clinical trial
Gallbladder Complications : Another significant claim involves Ozempic and gallbladder disease claims, where patients allege they developed gallbladder issues post-treatment
Alternatively, they may prescribe other drugs off-label because weight loss is a known side effect
Problems paying for prescription drugs Source: Montero, et al KFF, November 14, 2025 Implications for employers: Plan member interest in GLP-1 medications to treat obesity and cardiometabolic disease is likely to continue to increase
This means that generic pharmaceutical companies cant make and sell a cheaper generic version until the patent expires or is no longer valid
PlexusDx uses flat-rate monthly pricing: semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and stay that price regardless of dose level